Neuropsychopharmacology
- ACNP 62nd Annual Meeting: Poster Abstracts P501 – P75310 months ago
- ACNP 62nd Annual Meeting: Panels, Mini-Panels and Study Groups10 months ago
- ACNP 62nd Annual Meeting: Keyword Index10 months ago
- ACNP 62nd Annual Meeting: Poster Abstracts P251 – P50010 months ago
- ACNP 62nd Annual Meeting: Author Index10 months ago
- ACNP 62nd Annual Meeting: Poster Abstracts P1 – P25010 months ago
- Inhibition of asparagine endopeptidase (AEP) effectively treats sporadic Alzheimer’s disease in mice10 months ago
Journal of Psychopharmacology
- The influence of stimulus onset asynchrony, task order, sex and hormonal contraception on prepulse inhibition and prepulse facilitation: Methodological considerations for drug and imaging research2 years ago
- Clinical correlates of early onset antipsychotic treatment resistance2 years ago
- Validation of ratings on the six-item Positive and Negative Syndrome Scale obtained via the Simplified Negative and Positive Symptoms Interview among outpatients with schizophrenia2 years ago
- Therapeutic (Sub)stance: Current practice and therapeutic conduct in preparatory sessions in substance-assisted psychotherapy—A systematized review2 years ago
- D2-like receptor activation by intranasal dopamine attenuates fear responses induced by electrical stimulation of the dorsal periaqueductal grey matter, but fails to reduce aversion to pit vipers and T-maze performance2 years ago
- Efficacy of aripiprazole as adjunctive therapy in major depressive disorder with somatic symptoms: A randomized, double-blind, placebo-controlled trial with clinical and electroencephalography evidence2 years ago
- Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze2 years ago
European Neuropsychopharmacology
- Premise, promise and challenges of MDMA assisted therapy for PTSD2 years ago
- Robotics in psychiatry – Fiction or reality?2 years ago
- Improving drug development in precision psychiatry by ameliorating cognitive biases2 years ago
- A shared decision journey to bridge the gap between treatment recommendation and low adherence?2 years ago
- Neuroimaging revealed long-lasting glucose metabolism changes to morphine withdrawal in rats pretreated with the cannabinoid agonist CP-55,940 during periadolescence2 years ago
- Treating major depressive disorder with mixed features2 years ago
- New biomarkers in mood disorders: Insights from immunopsychiatry and neuroimaging2 years ago